These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30745840)

  • 1. RRM2 is a potential prognostic biomarker with functional significance in glioma.
    Sun H; Yang B; Zhang H; Song J; Zhang Y; Xing J; Yang Z; Wei C; Xu T; Yu Z; Xu Z; Hou M; Ji M; Zhang Y
    Int J Biol Sci; 2019; 15(3):533-543. PubMed ID: 30745840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMB8 regulates glioma cell migration, proliferation, and apoptosis through modulating ERK1/2 and PI3K/AKT signaling pathways.
    Yang BY; Song JW; Sun HZ; Xing JC; Yang ZH; Wei CY; Xu TY; Yu ZN; Zhang YN; Wang YF; Chang H; Xu ZP; Hou M; Ji MJ; Zhang YS
    Biomed Pharmacother; 2018 Apr; 100():205-212. PubMed ID: 29428669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CDKL3 as a critical regulator in development of glioma through regulating RRM2 and the JNK signaling pathway.
    Cui Y; Yang Z; Wang H; Yan Y; Huang Q; Gong Z; Hong F; Zhang X; Li W; Chen J; Xu T
    Cancer Sci; 2021 Aug; 112(8):3150-3162. PubMed ID: 34097336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
    Han J; Hu J; Sun F; Bian H; Tang B; Fang X
    Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.
    Han P; Lin ZR; Xu LH; Zhong Q; Zhu XF; Liang FY; Cai Q; Huang XM; Zeng MS
    Mol Med Rep; 2015 Jul; 12(1):401-9. PubMed ID: 25695839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RRM2 promotes the progression of human glioblastoma.
    Li C; Zheng J; Chen S; Huang B; Li G; Feng Z; Wang J; Xu S
    J Cell Physiol; 2018 Oct; 233(10):6759-6767. PubMed ID: 29667764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma.
    Yang M; Yao P; Lang X; Li X; Zhang D
    Bioengineered; 2021 Dec; 12(2):12800-12811. PubMed ID: 34895038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer.
    Tang Q; Wu L; Xu M; Yan D; Shao J; Yan S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1368-1379. PubMed ID: 32763454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis.
    Fu K; Zhang K; Zhang X
    Orphanet J Rare Dis; 2022 Mar; 17(1):119. PubMed ID: 35248107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway.
    Shan J; Wang Z; Mo Q; Long J; Fan Y; Cheng L; Zhang T; Liu X; Wang X
    Pancreatology; 2022 Apr; 22(3):401-413. PubMed ID: 35300916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma.
    Das B; Jain N; Mallick B
    Gene; 2022 Jan; 808():145988. PubMed ID: 34624457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer.
    Aird KM; Li H; Xin F; Konstantinopoulos PA; Zhang R
    Cell Cycle; 2014; 13(2):199-207. PubMed ID: 24200970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer.
    Wang N; Zhan T; Ke T; Huang X; Ke D; Wang Q; Li H
    Br J Cancer; 2014 Feb; 110(4):1034-44. PubMed ID: 24423925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy.
    Li J; Pang J; Liu Y; Zhang J; Zhang C; Shen G; Song L
    Oncol Rep; 2018 Jul; 40(1):355-360. PubMed ID: 29749541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers.
    Huang Y; Liu X; Wang YH; Yeh SD; Chen CL; Nelson RA; Chu P; Wilson T; Yen Y
    Urol Oncol; 2014 Jan; 32(1):51.e9-19. PubMed ID: 24360663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SATB1 promotes the malignant of human non-Hodgkin lymphoma by activating the ribonucleotide reductase 
small subunit M2].
    Yan D; Wang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1155-1162. PubMed ID: 27932760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Ribonucleotide Reductase M2 and NF-κB Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer.
    Shah KN; Wilson EA; Malla R; Elford HL; Faridi JS
    Mol Cancer Ther; 2015 Nov; 14(11):2411-21. PubMed ID: 26333382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2/Akt/MMP-9 pathway.
    Ban Z; Li Z; Xing S; Ye Y
    PLoS One; 2024; 19(5):e0303593. PubMed ID: 38820515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.